{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T07:01:18Z","timestamp":1788850878574,"version":"build-2803163510"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["General Hospital Psychiatry"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.genhosppsych.2020.06.012","type":"journal-article","created":{"date-parts":[[2020,6,26]],"date-time":"2020-06-26T15:49:19Z","timestamp":1593186559000},"page":"34-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Aripiprazole for the treatment of delusional disorders: A systematic review"],"prefix":"10.1016","volume":"66","author":[{"given":"Alessandro","family":"Miola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedetta","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2102-416X","authenticated-orcid":false,"given":"Fabio","family":"Sambataro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommaso","family":"Toffanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0005","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/JCP.0000000000000920","article-title":"Successful treatment of delusional disorder with aripiprazole long-acting injection","volume":"38","author":"Diefenderfer","year":"2018","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2020.06.012_bb0010","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/13546805.2019.1584098","article-title":"Cognitive neuropsychiatric analysis of an additional large Capgras delusion case series","volume":"24","author":"Currell","year":"2019","journal-title":"Cogn Neuropsychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2020.06.012_bb0015","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1097\/JCP.0000000000000595","article-title":"A systematic review on the pharmacological treatment of delusional disorder","volume":"36","author":"Mu\u00f1oz-Negro","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0020","series-title":"The medical basis of psychiatry","first-page":"137","article-title":"Delusional disorders","author":"Andreas","year":"2016"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0025","series-title":"Textbook of postgraduate psychiatry (2 volumes)","first-page":"456","article-title":"Delusional disorders","author":"Ahuja","year":"2018"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0030","series-title":"Diagnostic and statistical manual of mental disorders","article-title":"DSM-5 diagnostic classification","author":"American Psychiatric Association","year":"2013"},{"issue":"2","key":"10.1016\/j.genhosppsych.2020.06.012_bb0035","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1159\/000284805","article-title":"Outcome in delusional disorder in different periods of time","volume":"26","author":"Opjordsmoen","year":"1993","journal-title":"Psychopathology"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0040","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/j.1440-1819.2008.01812.x","article-title":"Successful treatment of delusional disorder with low-dose aripiprazole","volume":"62","author":"Miyamoto","year":"2008","journal-title":"Psychiatry Clin Neurosci"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0045","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/bsl.683","article-title":"Pharmacotherapy of delusional disorders in the context of offending and the potential for compulsory treatment","volume":"24","author":"Smith","year":"2006","journal-title":"Behav Sci Law"},{"issue":"10","key":"10.1016\/j.genhosppsych.2020.06.012_bb0050","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1177\/070674379504001008","article-title":"An overview of treatment in paranoia\/delusional disorder","volume":"40","author":"Munro","year":"1995","journal-title":"Can J Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2020.06.012_bb0055","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/0190-9622(93)70284-Z","article-title":"Delusional parasitosis: a dermatologic, psychiatric, and pharmacologic approach","volume":"29","author":"Driscoll","year":"1993","journal-title":"J Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2020.06.012_bb0060","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2165\/00128071-200405050-00007","article-title":"Pimozide in dermatologic practice","volume":"5","author":"Lorenzo","year":"2004","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2020.06.012_bb0065","doi-asserted-by":"crossref","first-page":"55","DOI":"10.2340\/00015555625558","article-title":"Delusions of infestation treated by pimozide: a double-blind crossover clinical study","volume":"62","author":"Hamann","year":"1982","journal-title":"Acta Derm Venereol"},{"issue":"34","key":"10.1016\/j.genhosppsych.2020.06.012_bb0070","first-page":"2191","article-title":"Delusions of parasite infestation treated with pimozide (Orap\u00ae)","volume":"142","author":"Avnstorp","year":"1980","journal-title":"Ugeskr Laeger"},{"issue":"11","key":"10.1016\/j.genhosppsych.2020.06.012_bb0075","first-page":"CD001949","article-title":"Pimozide for schizophrenia or related psychoses","author":"Mothi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0080","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.pnpbp.2007.01.001","article-title":"Aripiprazole in delusional parasitosis: case report","volume":"31","author":"Rocha","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2020.06.012_bb0085","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0033-3182(95)71615-2","article-title":"Risperidone and the treatment of delusions of parasitosis in an elderly patient","volume":"36","author":"Gallucci","year":"1995","journal-title":"Psychosomatics"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0090","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1176\/ajp.153.4.578","article-title":"Treatment of somatic delusional disorder with atypical antipsychotic agents","volume":"153","author":"Songer","year":"1996","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2190\/JJY8-P3YW-MN9Y-WBTX","article-title":"Risperidone in the treatment of delusions of infestation","volume":"27","author":"De Le\u00f3n","year":"1997","journal-title":"Int J Psychiatry Med"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0100","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1067\/mjd.2000.106510","article-title":"Therapeutic update: use of risperidone for the treatment of monosymptomatic hypochondriacal psychosis","volume":"43","author":"Elmer","year":"2000","journal-title":"J Am Acad Dermatol"},{"issue":"3\u20134","key":"10.1016\/j.genhosppsych.2020.06.012_bb0105","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/10401230309085693","article-title":"\u201cAtypical antipsychotics in the treatment of delusional parasitosis\u201d","volume":"15","author":"Wenning","year":"2003","journal-title":"Ann Clin Psychiatry"},{"issue":"1","key":"10.1016\/j.genhosppsych.2020.06.012_bb0110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.47102\/annals-acadmedsg.V34N1p141","article-title":"Delusional parasitosis: treatment with atypical antipsychotics","volume":"34","author":"Freudenmann","year":"2005","journal-title":"Ann Acad Med Singapore"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0115","doi-asserted-by":"crossref","DOI":"10.1001\/archderm.142.3.352","article-title":"Successful treatment of delusions of parasitosis with olanzapine","volume":"142","author":"Meehan","year":"2006","journal-title":"Arch Dermatol"},{"issue":"1","key":"10.1016\/j.genhosppsych.2020.06.012_bb0120","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.genhosppsych.2005.08.008","article-title":"Delusional parasitosis or Ekbom syndrome: a case series","volume":"28","author":"Nicolato","year":"2006","journal-title":"Gen Hosp Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2020.06.012_bb0125","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/070674370605100207","article-title":"Recent advances in the treatment of delusional disorder","volume":"51","author":"Manschreck","year":"2006","journal-title":"Can J Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0130","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/JCP.0b013e3182905796","article-title":"Comparative efficacy and acceptability of existing pharmacotherapies for delusional disorder","volume":"33","author":"Mews","year":"2013","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0135","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/bjd.12392","article-title":"Delusional infestation and patient adherence to treatment: an observational study","volume":"169","author":"Ahmed","year":"2013","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0140","first-page":"433","article-title":"Aripiprazole in delusional disorder","volume":"7","author":"Duvar","year":"2010","journal-title":"Eur J Gen Med"},{"issue":"9","key":"10.1016\/j.genhosppsych.2020.06.012_bb0145","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/pcn.12200","article-title":"Aripiprazole in difficult-to-treat delusional disorder with co-morbid epilepsy","volume":"68","author":"Garg","year":"2014","journal-title":"Psychiatry Clin Neurosci"},{"issue":"2","key":"10.1016\/j.genhosppsych.2020.06.012_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5455\/apd.256509","article-title":"Aripiprazole and fluoxetine in the treatment of delusional parasitosis: a case report","volume":"18","author":"Ya\u011fc\u0131","year":"2017","journal-title":"Anadolu Psikiyatr Derg"},{"issue":"9","key":"10.1016\/j.genhosppsych.2020.06.012_bb0155","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1097\/01.chi.0000132834.43268.10","article-title":"Aripiprazole and psychotherapy for delusional disorder, erotomanic type","volume":"43","author":"Myers","year":"2004","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0160","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.psym.2011.01.035","article-title":"Successful use of aripiprazole for delusional disorder with comorbid pituitary microadenoma: a case report","volume":"52","author":"Jayaram","year":"2011","journal-title":"Psychosomatics"},{"issue":"10202","key":"10.1016\/j.genhosppsych.2020.06.012_bb0165","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(19)31135-3","article-title":"Comparative efficacy and tolerability of 32 oral antipsychotics for the acute treatment of adults with multi-episode schizophrenia: a systematic review and network meta-analysis","volume":"394","author":"Huhn","year":"2019","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.genhosppsych.2020.06.012_bb0170","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"issue":"7","key":"10.1016\/j.genhosppsych.2020.06.012_bb0175","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0269881107082905","article-title":"Delusional disorder, somatic type treated with aripiprazole-mirtazapine combination","volume":"22","author":"Dimopoulos","year":"2008","journal-title":"J Psychopharmacol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0180","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1097\/WNN.0b013e318185e6bd","article-title":"An olfactory reference syndrome successfully treated by aripiprazole augmentation of antidepressant therapy","volume":"21","author":"Riccardo Muffatti","year":"2008","journal-title":"Cogn Behav Neurol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0185","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/archdermatol.2009.20","article-title":"Treatment of delusional parasitosis with aripiprazole","volume":"145","author":"Benn\u00e0ssar","year":"2009","journal-title":"Arch Dermatol"},{"issue":"2","key":"10.1016\/j.genhosppsych.2020.06.012_bb0190","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/JCP.0b013e3182856850","article-title":"Aripiprazole in the treatment of delusional parasitosis with ocular and dermatologic presentations","volume":"33","author":"Huang","year":"2013","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0195","doi-asserted-by":"crossref","first-page":"103652","DOI":"10.1155\/2011\/103652","article-title":"Delusional infestation in a patient with renal failure, metabolic syndrome, and chronic cerebrovascular disease treated with aripiprazole: a case report","volume":"2011","author":"Carpiniello","year":"2011","journal-title":"Case Rep Med"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0200","first-page":"257","article-title":"Neural correlates of delusional infestation responding to aripiprazole monotherapy: a case report","volume":"11","author":"Ponson","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"5","key":"10.1016\/j.genhosppsych.2020.06.012_bb0205","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2340\/00015555-0909","article-title":"Delusional parasitosis and the matchbox sign revisited: the international perspective","volume":"90","author":"Freudenmann","year":"2010","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0210","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jaad.2008.06.033","article-title":"A clinical paradigm of delusions of parasitosis","volume":"59","author":"Sandoz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0215","doi-asserted-by":"crossref","first-page":"297","DOI":"10.7205\/MILMED-D-03-0108","article-title":"Multiple sclerosis presenting with erotomanic delusions in the context of \u2018don\u2019t ask, don\u2019t tell\u2019","volume":"174","author":"Smith","year":"2009","journal-title":"Mil Med"},{"issue":"2","key":"10.1016\/j.genhosppsych.2020.06.012_bb0220","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1097\/PRA.0000000000000368","article-title":"Aripiprazole and delusional disorder","volume":"25","author":"Iannuzzi","year":"2019","journal-title":"J Psychiatr Pract"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0225","doi-asserted-by":"crossref","first-page":"260","DOI":"10.4103\/0253-7176.183082","article-title":"Aripiprazole-induced hyperprolactinemia in a young female with delusional disorder","volume":"38","author":"Joseph","year":"2016","journal-title":"Indian J Psychol Med"},{"issue":"2","key":"10.1016\/j.genhosppsych.2020.06.012_bb0230","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/WNF.0000000000000207","article-title":"Two cases of oral somatic delusions ameliorated with brain perfusion asymmetry: a case report","volume":"40","author":"Umezaki","year":"2017","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0235","series-title":"ATC classification index with DDDs","year":"2019"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0240","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2020.109941","article-title":"Antipsychotic-induced Hyperprolactinemia in aging populations: prevalence, implications, prevention and management","volume":"101","author":"Gonz\u00e1lez-Rodr\u00edguez","year":"2020","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2020.06.012_bb0245","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4088\/JCP.v68n0206","article-title":"Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine","volume":"68","author":"Kane","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0250","first-page":"pgs","article-title":"The pharmacogenetics of aripiprazole-induced hyperprolactinemia: what do we know?","author":"Koller","year":"2020","journal-title":"Pharmacogenomics"},{"issue":"2\u20133","key":"10.1016\/j.genhosppsych.2020.06.012_bb0255","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0920-9964(03)00050-1","article-title":"Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials","volume":"61","author":"Marder","year":"2003","journal-title":"Schizophr Res"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0260","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2165\/00023210-200418040-00005","article-title":"Dopamine partial agonists: a new class of antipsychotic","volume":"18","author":"Lieberman","year":"2004","journal-title":"CNS Drugs"},{"issue":"1","key":"10.1016\/j.genhosppsych.2020.06.012_bb0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"issue":"6","key":"10.1016\/j.genhosppsych.2020.06.012_bb0270","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0893-133X(98)00099-2","article-title":"Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes","volume":"20","author":"Lawler","year":"1999","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"10.1016\/j.genhosppsych.2020.06.012_bb0275","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1038\/sj.npp.1300203","article-title":"Aripiprazole, a novel atypical antipsychotic drug with a unique and robust pharmacology","volume":"28","author":"Shapiro","year":"2003","journal-title":"Neuropsychopharmacology"},{"issue":"5","key":"10.1016\/j.genhosppsych.2020.06.012_bb0280","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0149-2918(04)90066-5","article-title":"Aripiprazole: a comprehensive review of its pharmacology, clinical efficacy, and tolerability","volume":"26","author":"DeLeon","year":"2004","journal-title":"Clin Ther"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0285","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/10401230490487007","article-title":"Aripiprazole: review of its pharmacology and therapeutic use in psychiatric disorders","volume":"16","author":"Gupta","year":"2004","journal-title":"Ann Clin Psychiatry"},{"issue":"11","key":"10.1016\/j.genhosppsych.2020.06.012_bb0290","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2165\/00023210-200721110-00004","article-title":"Adverse effects of atypical antipsychotics: differential risk and clinical implications","volume":"21","author":"Haddad","year":"2007","journal-title":"CNS Drugs"},{"issue":"12","key":"10.1016\/j.genhosppsych.2020.06.012_bb0295","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1517\/14656566.6.12.2091","article-title":"Aripiprazole","volume":"6","author":"Fleischhacker","year":"2005","journal-title":"Expert Opin Pharmacother"},{"issue":"8","key":"10.1016\/j.genhosppsych.2020.06.012_bb0300","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1517\/14656566.9.8.1279","article-title":"Proposed strategies for successful clinical management with aripiprazole","volume":"9","author":"Mago","year":"2008","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"10.1016\/j.genhosppsych.2020.06.012_bb0305","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1001\/archpsyc.60.7.681","article-title":"Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaff ective disorder","volume":"60","author":"Potkin","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0310","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1192\/bjp.152.6.851","article-title":"Monosymptomatic hypochondriasis treated with a tricyclic antidepressant","volume":"152","author":"Fernando","year":"1988","journal-title":"Br J Psychiatry"},{"issue":"2","key":"10.1016\/j.genhosppsych.2020.06.012_bb0315","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1097\/00004583-198803000-00010","article-title":"Clomipramine treatment of delusional disorder-somatic type","volume":"27","author":"Sondheimer","year":"1988","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0320","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00004850-199905030-00006","article-title":"Clomipramine treatment of delusional disorder, somatic type","volume":"14","author":"Wada","year":"1999","journal-title":"Int Clin Psychopharmacol"},{"issue":"5","key":"10.1016\/j.genhosppsych.2020.06.012_bb0325","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/hup.590","article-title":"Paroxetine treatment of delusional disorder, somatic type","volume":"19","author":"Hayashi","year":"2004","journal-title":"Hum Psychopharmacol"},{"issue":"9","key":"10.1016\/j.genhosppsych.2020.06.012_bb0330","first-page":"732","article-title":"The neuroleptic treatment of delusional parasitosis. First experiences with aripiprazole","volume":"59","author":"Kumbier","year":"2008","journal-title":"Hautarzt"},{"key":"10.1016\/j.genhosppsych.2020.06.012_bb0335","first-page":"68","article-title":"Metabolic considerations in the use of antipsychotic medications: a review of recent evidence","volume":"Suppl 1","author":"Newcomer","year":"2007","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0340","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/026988110401800308","article-title":"Mechanism of action of aripiprazole predicts clinical efficacy and a favourable side-effect profile","volume":"18","author":"Hirose","year":"2004","journal-title":"J Psychopharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.genhosppsych.2020.06.012_bb0345","article-title":"New generation antipsychotics in the treatment of schizophrenia: dopamine stabilizing agents and aripiprazole","volume":"18","author":"Alptekin","year":"2008","journal-title":"Klin Psikofarmakol Bul"},{"issue":"10","key":"10.1016\/j.genhosppsych.2020.06.012_bb0350","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00228-018-2498-1","article-title":"Efficacy and safety of aripiprazole for the treatment of schizophrenia: an overview of systematic reviews","volume":"74","author":"Ribeiro","year":"2018","journal-title":"Eur J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.genhosppsych.2020.06.012_bb0355","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1080\/14740338.2020.1713091","article-title":"Update on weight-gain caused by antipsychotics: a systematic review and meta-analysis","volume":"19","author":"Barton","year":"2020","journal-title":"Expert Opin Drug Saf"},{"issue":"18","key":"10.1016\/j.genhosppsych.2020.06.012_bb0360","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1007\/s00213-015-4024-9","article-title":"The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach","volume":"232","author":"Polcwiartek","year":"2015","journal-title":"Psychopharmacol"},{"issue":"4","key":"10.1016\/j.genhosppsych.2020.06.012_bb0365","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1176\/appi.psy.50.4.317","article-title":"Evidence for the partial dopamine-receptor agonist aripiprazole as a first-line treatment of psychosis in patients with iatrogenic or tumorogenic hyperprolactinemia","volume":"50","author":"Hoffer","year":"2009","journal-title":"Psychosomatics"},{"issue":"7","key":"10.1016\/j.genhosppsych.2020.06.012_bb0370","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40263-015-0262-y","article-title":"Antipsychotic drug use and the risk of seizures: follow-up study with a nested case-control analysis","volume":"29","author":"Bloechliger","year":"2015","journal-title":"CNS Drugs"}],"container-title":["General Hospital Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834320300967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163834320300967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:51:39Z","timestamp":1759013499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163834320300967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":74,"alternative-id":["S0163834320300967"],"URL":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2020.06.012","relation":{},"ISSN":["0163-8343"],"issn-type":[{"value":"0163-8343","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aripiprazole for the treatment of delusional disorders: A systematic review","name":"articletitle","label":"Article Title"},{"value":"General Hospital Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.genhosppsych.2020.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}